Chapter 2 Summary and Highlights
- Market Outlook
- Market Summary
Chapter 3 Market and Technology Background
- Introduction
- Types of Biomarkers
- Future Outlook
Chapter 4 Market Dynamics
- Market Dynamics Snapshot
- Market Drivers
- Unmet Needs in Cancer Screening
- Government Measures for Cancer Screening
- Market Restraints
- Risk of False Positives or False Negatives
- Regulatory and Reimbursement Uncertainty
Chapter 5 Market Breakdown by Test Type
- Global Multi-Cancer Diagnostic Test Market, by Test Type
- Market Size and Forecast
- Laboratory Developed Tests
- In-Vitro Diagnostic Tests
Chapter 6 Market Breakdown by End User
- Global Multi-Cancer Diagnostic Test Market, by End User
- Hospitals
- Diagnostic Laboratories
- Research Institutions
Chapter 7 Market Breakdown by Region
- Global Multi-Cancer Diagnostic Test Market, by Region
- The U.S.
- Europe
- Emerging Markets
Chapter 8 Emerging Technologies
- Introduction
- Identification of Tissue of Origin
- Fragmentomics and Tumor-Educated Platelets
- Liquid Biopsy with Imaging Data Analysis
Chapter 9 Competitive Landscape
- Porter's Five Forces Analysis
- Threat of New Entrants
- Threat of Substitutes
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Degree of Competition
- Recent Developments in the Multi-Cancer Diagnostic Market
- Clinical Trial Activities
Chapter 10 Company Profiles
- ANCHORDX MEDICAL CO. LTD.
- BURNING ROCK BIOTECH LTD.
- DELFI DIAGNOSTICS
- EXACT SCIENCES CORP.
- FREENOME HOLDINGS INC.
- GENECAST INC.
- GRAIL INC.
- GUARDANT HEALTH INC.
List of Tables
Summary Table A: Global Multi-Cancer Diagnostic Test Market, Through 2028
Summary Table B: Global Multi-Cancer Diagnostic Test Market, by Region, Through 2028
Table 1: Cancer Screening Guidelines
Table 2: Global Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 3: Global Multi-Cancer Diagnostic Test Market, by Laboratory Developed Tests Type, by Region, Through 2028
Table 4: Global Multi-Cancer Diagnostic Test Market, by In-Vitro Diagnostic Test Type, by Region, Through 2028
Table 5: Global Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 6: Global Multi-Cancer Diagnostic Test Market Used in Hospitals, by Region, Through 2028
Table 7: Global Multi-Cancer Diagnostic Test Market Used in Diagnostic Laboratories, by Region, Through 2028
Table 8: Global Multi-Cancer Diagnostic Test Market Used in Research Institutions, by Region, Through 2028
Table 9: Global Multi-Cancer Diagnostic Test Market, by Region, Through 2028
Table 10: The U.S. Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 11: The U.S. Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 12: European Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 13: European Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 14: Emerging Multi-Cancer Diagnostic Test Market, by Test Type, Through 2028
Table 15: Emerging Multi-Cancer Diagnostic Test Market, by End User, Through 2028
Table 16: Emerging Multi-Cancer Diagnostic Test Market, by Country, Through 2028
Table 17: Porter’s Five Force Analysis of the Multi-Cancer Diagnostic Test Market
Table 18: Recent Developments in Multi-Cancer Diagnostics, 2022 and 2023
Table 19: Ongoing Clinical Trials for Multi-Cancer Diagnostic Tests
Table 20: MCD Technologies of Competitor Products
Table 21: AnchorDx Medical Co. Ltd.: Company Snapshot
Table 22: Burning Rock Biotech Ltd.: Company Snapshot
Table 23: Delfi Diagnostics Inc.: Company Snapshot
Table 24: Exact Sciences Corp.: Company Snapshot
Table 25: Freenome Holdings Inc.: Company Snapshot
Table 26: Genecast Inc.: Company Snapshot
Table 27: Grail Inc.: Company Snapshot
Table 28: Guardant Health Inc.: Company Snapshot
List of Figures
Summary Figure A: Global Multi-Cancer Diagnostic Test Market, 2020-2028
Summary Figure B: Global Multi-Cancer Diagnostic Test Market, by Region, 2020-2028
Figure 1: Potential Benefits of Multi-Cancer Diagnostic Tests
Figure 2: Multi-Cancer Diagnostic Tests Market Dynamics
Figure 3: Evidence Generation Required for Multi-Cancer Diagnostic Tests
Figure 4: Global Multi-Cancer Diagnostic Test Market, by Test Type, 2020-2028
Figure 5: Global Multi-Cancer Diagnostic Test Market Share, by Test Type, 2022
Figure 6: Global Multi-Cancer Diagnostic Test Market, by End User, 2020-2028
Figure 7: Global Multi-Cancer Diagnostic Test Market Share, by End User, 2022
Figure 8: Global Multi-Cancer Diagnostic Test Market, by Region, 2020-2028
Figure 9: Global Multi-Cancer Diagnostic Test Market Share, by Region, 2022
Figure 10: Emerging Technologies in the Multi-Cancer Diagnosis Test Market